This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Chikako Setoguchi - Innovator in Therapeutic Agents
Introduction
Chikako Setoguchi is an inventor based in Ikoma-shi, Japan. He is known for his work in the field of pharmacology, particularly focusing on therapeutic agents for TRPV1-mediated diseases. Although he currently holds no granted patents, his research has the potential to contribute significantly to medical science.
Latest Patent Applications
Chikako Setoguchi's notable patent application is titled "THERAPEUTIC AGENT FOR TRPV1-MEDIATED DISEASE." The objective of this invention is to discover a novel pharmacological action of a urea compound characterized by a specific general formula. The urea compound or its salt exhibits an excellent therapeutic effect on TRPV1-mediated diseases. In the formula, A represents a lower alkylene or alkenylene group, while R can be a hydrogen atom, an alkyl group, or an alkenyl group, which may have substituents. Additionally, R and R can be the same or different, representing a hydrogen atom or a lower alkyl group that may be substituted by a monocyclic cycloalkyl group, a polycyclic cycloalkyl group, or an aryl group.
Conclusion
Chikako Setoguchi's innovative approach to developing therapeutic agents highlights the importance of research in pharmacology. His work on TRPV1-mediated diseases could pave the way for new treatments in the future.